Tramadol and Deafness transitory - a phase IV clinical study of FDA data
Summary:
Deafness transitory is found among people who take Tramadol, especially for people who are female, 60+ old.
The phase IV clinical study analyzes which people take Tramadol and have Deafness transitory. It is created by eHealthMe based on reports of 194,214 people who have side effects when taking Tramadol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
194,214 people reported to have side effects when taking Tramadol.
Among them, 270 people (0.14%) have Deafness transitory.
What is Tramadol?
Tramadol has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 200,066 Tramadol users for its effectiveness, alternative drugs and more.
What is Deafness transitory?
Deafness transitory (deafness temporary) is found to be associated with 607 drugs and 417 conditions by eHealthMe.
Number of Tramadol and Deafness transitory reports submitted per year:
Gender of people who have Deafness transitory when taking Tramadol*:
Age of people who have Deafness transitory when taking Tramadol *:
Common drugs people take besides Tramadol *:
Common side effects people have besides Deafness transitory *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Tramadol and have Deafness transitory?
Check whether Deafness transitory is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
Related studies
How severe was Deafness transitory and when was it recovered:
Expand to all the drugs that have ingredients of tramadol hydrochloride:
Alternative drugs to, pros and cons of Tramadol:
- Tramadol (200,066 reports)
Common Tramadol side effects:
- Pain: 14,785 reports
- Fatigue (feeling of tiredness): 12,058 reports
- Drug ineffective: 10,171 reports
- Headache (pain in head): 9,302 reports
- Diarrhea: 9,053 reports
Browse all side effects of Tramadol:
a b c d e f g h i j k l m n o p q r s t u v w x y zDeafness transitory treatments and more:
- Deafness transitory (1,025 reports)
COVID vaccines that are related to Deafness transitory:
- Deafness transitory in Moderna COVID Vaccine
- Deafness transitory in Pfizer BioNTech Covid Vaccine
- Deafness transitory in Johnson and Johnson Covid Vaccine
Common drugs associated with Deafness transitory:
- Humira: 320 reports
- Methotrexate: 306 reports
- Enbrel: 293 reports
- Arava: 274 reports
- Tramadol: 270 reports
- Aspirin: 223 reports
- Motrin: 222 reports
- Naprosyn: 215 reports
- Plaquenil: 186 reports
- Diclofenac: 167 reports
All the drugs that are associated with Deafness transitory:
- Deafness transitory (607 drugs)
Common conditions associated with Deafness transitory:
- Rheumatoid arthritis: 327 reports
All the conditions that are associated with Deafness transitory:
- Deafness transitory (417 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on tramadol hydrochloride (the active ingredients of Tramadol) and Tramadol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Macrodantin and Vitamins drug interaction - 7 seconds ago
- Acetylcysteine and Duloxetine Hydrochloride drug interaction - 10 seconds ago
- Tolterodine and Weight Increased - 10 seconds ago
- Trulicity and Metabolic Acidosis - 10 seconds ago
- Metronidazole and Burning Mouth Syndrome - 12 seconds ago
- Lipitor and Pseudopolyp - 14 seconds ago
- Metoprolol Succinate and Urine Protein/Creatinine Ratio Increased - 16 seconds ago
- Clotrimazole and Tylenol drug interaction - 17 seconds ago
- Pantoprazole and Anal Infection - 19 seconds ago
- Seasonique and Adderall drug interaction - 19 seconds ago